Journal: Science translational medicine
Article Title: Targeted antibody and cytokine cancer immunotherapies through collagen affinity
doi: 10.1126/scitranslmed.aau3259
Figure Lengend Snippet: We used three tumor models to study efficacy of targeted immunotherapy, namely the B16F10 melanoma model, the CT26 colon carcinoma model, and the MMTV-PyMT breast cancer model. (A, F) 5 × 105 B16F10 cells were inoculated on back skin, (B, G) 5 × 105 CT26 cells were inoculated on back skin, (C, D, H-K) 5 × 105 MMTV-PyMT cells were inoculated on the right mammary fat pad day 0. (A-D) CBD-αCTLA4 + CBD-PD-L1 (CBD-CPI), αCTLA4 + αPD-L1 (CPI) or PBS was administered on (A) day 4, (B) day 5, (C, D) day 7. (A) CBD- and unmodified CPI were injected i.v., and PlGF-2123–144-CPI was injected peritumorally (p.t.). Antibody doses per administration are indicated on the figure. (A-C) Graphs depict tumor volume until the first mouse died and (D) survival rate. (E) 30 days after the first tumor inoculation in the right mammary gland fat pad, 5 × 105 MMTV-PyMT cells were again inoculated into the left mammary gland fat pad in CBD-CPI treated tumor-free survivors or in naïve mice. Numbers indicate how many mice remain tumor-free among total mice after 40 days of tumor re-challenge. (F) 5 × 105 B16F10 cells were inoculated on the back skin, (G) 5 × 105 CT26 cells were inoculated on the back skin, (H-K) 5 × 105 MMTV-PyMT cells were inoculated on the right mammary fat pad day 0. (F-I) 6 μg IL-2 or equimolar CBD-IL-2 was injected i.v. on (F) day 4, (G) day 5, (H, I) day 7. (F-H) Graphs depict tumor volume until the first mouse died and (I) survival rate. (J, K) After 7, 14, and 21 days from tumor inoculation, CBD-αCTLA4 + CBD-αPD-L1 (CBD-CPI) + CBD-IL-2, αCTLA4 + αPD-L1 (CPI) + IL-2 or PBS were injected i.v.. (J) Graphs depict tumor volume until the first mouse died and (K) survival rate. Numbers indicate how many mice remained tumor-free among total mice 100 days after tumor inoculation. (A) PBS, n = 9; CPI 100 μg and CBD-CPI 25 μg, n = 8; CBD-CPI 100 μg and PlGF-2123–144-CPI 100 μg, n = 7. (B) PBS and CPI 25 μg, n = 11; CPI 100 μg and CBD-CPI 25 μg, n = 10; CBD-CPI 100 μg, n = 9. (C, D) CBD-CPI, n = 12; other groups, n = 11. (E-G) n = 6. (H, I) PBS, n = 10; other groups, n = 11. (J, K) PBS, n = 10; other groups, n = 13. Tumor volumes are presented as mean ± SEM. Two experimental replicates. Statistical analyses were done using ANOVA with Tukey’s test for tumor size and Log-rank (Mantel-Cox) test for survival curves. *p < 0.05; **p < 0.01.
Article Snippet: The tissues were stained with hamster anti-human CD31 antibody (Abcam), goat anti-mouse IL-2 antibody (R and D systems), and rabbit anti-collagen I antibody (Abcam) for 1 hour at room temperature.
Techniques: Injection